Baseline Characteristics of Weight-Loss Success in a Personalized Nutrition Intervention: A Secondary Analysis
Authors:
- Collin J. PoppCPCollin J. Popp
- Chan WangCWChan Wang
- Lauren BerubeLBLauren Berube
- Margaret CurranMCMargaret Curran
- Lu HuLHLu Hu
- Mary Lou PompeiiMPMary Lou Pompeii
- Souptik BaruaSBSouptik Barua
- Huilin LiHLHuilin Li
- David E. St-JulesDSDavid E. St-Jules
- Antoinette SchoenthalerASAntoinette Schoenthaler
- Eran SegalESEran Segal
- Michael BergmanMBMichael Bergman
Open Access
Abstract
Background/Objectives: The aim of this secondary analysis is to determine the baseline characteristics that are associated with a higher likelihood of weight-loss success in a personalized nutrition intervention. Methods: Data were analyzed in adults with abnormal glucose metabolism and obesity from a 6-month behavioral counseling randomized clinical trial. Participants were randomized to two calorie-restricted diets: a low-fat diet (Standardized) or a personalized nutrition diet leveraging a machine learning algorithm (Personalized). The gradient boosting machine method was used to determine the baseline variables (i.e., age, weight-loss self-efficacy) that predicted successful weight loss (≥5%) at 6 months in each study arm separately, using repeated five-fold cross-validation with 100 repetitions. Results: A total of 155 participants (Personalized: n = 84 vs. Standardized: n = 71) contributed data (mean [standard deviation]: age, 59 [10] y; 66.5% female; 56.1% White; body mass index (BMI), 33.4 [4.6] kg/m2). In both arms, higher baseline self-efficacy for weight loss was a predictor of weight-loss success. Participants with a higher BMI (p < 0.0001) in the Standardized arm and those who were older (p < 0.0001) in the Personalized arm were more likely to achieve successful weight loss. Conclusions: Future weight-loss interventions may consider providing tailored behavioral support for individuals based on weight-loss self-efficacy, BMI, and age.Keywords
Funding Information
- American Heart Association (17SFRN33490004)
This publication has 34 references indexed in Scilit:
- A randomized clinical trial comparing low-fat with precision nutrition–based diets for weight loss: impact on glycemic variability and HbA1cThe American Journal of Clinical Nutrition, 2023
- Using a Metabotype Framework to Deliver Personalized Nutrition Improves Dietary Quality and Metabolic Health Parameters: A 12‐Week Randomized Controlled TrialMolecular Nutrition & Food Research, 2023
- Effect of a Personalized Diet to Reduce Postprandial Glycemic Response vs a Low-fat Diet on Weight Loss in Adults With Abnormal Glucose Metabolism and ObesityJAMA Network Open, 2022
- A double-blinded, randomized, parallel intervention to evaluate biomarker-based nutrition plans for weight loss: The PREVENTOMICS studyClinical Nutrition, 2022
- Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity ClinicObesity, 2021
- The Impact of COVID‐19 Stay‐At‐Home Orders on Health Behaviors in AdultsObesity, 2020
- The rationale and design of the personal diet study, a randomized clinical trial evaluating a personalized approach to weight loss in individuals with pre-diabetes and early-stage type 2 diabetesContemporary Clinical Trials, 2019
- Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with ObesityCell Metabolism, 2016
- Personalized Nutrition by Prediction of Glycemic ResponsesCell, 2015
- A Randomised Trial of a Weight Loss Intervention for Overweight and Obese People Diagnosed with Coronary Heart Disease and/or Type 2 DiabetesAnnals of Behavioral Medicine, 2012